Skip to main content

Advertisement

Fig. 4 | BMC Cancer

Fig. 4

From: Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy

Fig. 4

Treatment plan for stereotactic re-re-irradiation using rotational intensity-modulated radiotherapy (volumetric modulated arc therapy; VMAT). The 95%-isodose coverage of the prescribed 45 Gy is shown on fused MRI in axial and sagittal plane, with the latter demonstrating extensive craniocaudal (including prevertebral) tumor extension

Back to article page